$ORRF
ORRSTOWN FINANCIAL SERVICES INC Stock $orrf

$orrf Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000082615414000030 Filed on November 07, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue		$9.477M	$8.982M
YoY Change		5.51%	-16.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development		$254.0K	$282.0K
YoY Change		-9.93%
% of Gross Profit
Depreciation & Amortization	$770.0K	$560.0K	$720.0K
YoY Change	4.05%	-22.22%	7.46%
% of Gross Profit
Operating Expenses		$254.0K	$282.0K
YoY Change		-9.93%
Operating Profit
YoY Change
Interest Expense		$1.030M	$1.216M
YoY Change		-15.3%	-28.55%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.960M	$5.201M	$1.828M
YoY Change	0.68%	184.52%	-178.66%
Income Tax	-$16.16M	$24.00K	-$281.0K
% Of Pretax Income	-545.95%	0.46%	-15.37%
Net Earnings	$19.11M	$5.177M	$2.109M
YoY Change	552.22%	145.47%	-109.88%
Net Earnings / Revenue		54.63%	23.48%
Basic Earnings Per Share		$0.64	$0.26
Diluted Earnings Per Share	$2.351M	$0.64	$0.26
COMMON SHARES
Basic Shares Outstanding	8.264M shares	8.111M shares	8.091M shares
Diluted Shares Outstanding		8.122M shares	8.091M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$24.80M	$25.29M	$26.38M
YoY Change	-6.21%	-4.1%	-1.95%
Goodwill
YoY Change
Intangibles	$414.0K	$465.0K	$674.0K
YoY Change	-33.44%	-31.01%
Long-Term Investments
YoY Change
Other Assets	$15.40M	$0.00	$2.000M
YoY Change	492.31%	-100.0%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$1.190B	$1.183B	$1.212B
YoY Change	1.07%	-2.4%	-4.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.90M	$16.40M	$46.20M
YoY Change	9.17%	-64.5%	294.87%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$86.74M	$56.28M	$25.32M
YoY Change	46.94%	122.27%	109.26%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.90M	$16.40M	$46.20M
YoY Change	9.17%	-64.5%	294.87%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$16.40M
YoY Change		-100.0%	-56.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$16.40M
YoY Change		-100.0%	-56.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.90M	$16.40M	$46.20M
Total Long-Term Liabilities	$0.00	$0.00	$16.40M
Total Liabilities	$1.063B	$1.077B	$1.123B
YoY Change	-2.14%	-4.09%	-5.01%
SHAREHOLDERS EQUITY
Retained Earnings	$1.887M	-$17.23M	-$30.18M
YoY Change	-106.92%	-42.92%
Common Stock	$430.0K	$430.0K	$422.0K
YoY Change	1.9%	1.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$20.00K	$20.00K	$20.00K
YoY Change	0.0%	0.0%
Treasury Stock Shares	811.0 shares	811.0 shares	811.0 shares
Shareholders Equity	$127.3M	$106.5M	$89.64M
YoY Change
Total Liabilities & Shareholders Equity	$1.190B	$1.183B	$1.212B
YoY Change	1.07%	-2.4%	-4.48%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	$19.11M	$5.177M	$2.109M
YoY Change	552.22%	145.47%	-109.88%
Depreciation, Depletion And Amortization	$770.0K	$560.0K	$720.0K
YoY Change	4.05%	-22.22%	7.46%
Cash From Operating Activities	$1.250M	$5.330M	$1.650M
YoY Change	-92.49%	223.03%	135.71%
INVESTING ACTIVITIES
Capital Expenditures	-$120.0K	$30.00K	-$610.0K
YoY Change	-81.54%	-104.92%	29.79%
Acquisitions
YoY Change
Other Investing Activities	$3.790M	-$19.21M	-$3.000M
YoY Change	-107.96%	540.33%	-116.77%
Cash From Investing Activities	$3.670M	-$19.18M	-$3.610M
YoY Change	-107.6%	431.3%	-120.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.240M	9.570M	-12.00M
YoY Change	676.47%	-179.75%	-69.74%
NET CHANGE
Cash From Operating Activities	1.250M	5.330M	1.650M
Cash From Investing Activities	3.670M	-19.18M	-3.610M
Cash From Financing Activities	-9.240M	9.570M	-12.00M
Net Change In Cash	-4.320M	-4.280M	-13.96M
YoY Change	-86.84%	-69.34%	-35.16%
FREE CASH FLOW
Cash From Operating Activities	$1.250M	$5.330M	$1.650M
Capital Expenditures	-$120.0K	$30.00K	-$610.0K
Free Cash Flow	$1.370M	$5.300M	$2.260M
YoY Change	-92.08%	134.51%	93.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-5996000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-4894000	USD
CY2013Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	10874000	USD
CY2014Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	16375000	USD
CY2014Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	55000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4813000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123105000	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	123280000	USD
	us-gaap	Advertising Expense AdvertisingExpense	486000	USD
CY2013Q3	us-gaap	Advertising Expense AdvertisingExpense	142000	USD
CY2014Q3	us-gaap	Advertising Expense AdvertisingExpense	120000	USD
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	4545000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	140000	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	118000	USD
	us-gaap	Advertising Expense AdvertisingExpense	319000	USD
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	1294000	USD
CY2014Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	732000	USD
CY2013Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	2969000	USD
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	3340000	USD
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	5059000	USD
CY2014Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	2238000	USD
CY2013Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	1815000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	157000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	157000	USD
CY2013Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2014Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2013Q4	us-gaap	Assets Assets	1177812000	USD
CY2014Q3	us-gaap	Assets Assets	1183392000	USD
CY2014Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	402431000	USD
CY2014Q3	us-gaap	Available For Sale Equity Securities Amortized Cost Basis AvailableForSaleEquitySecuritiesAmortizedCostBasis	50000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	406943000	USD
CY2014Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	402563000	USD
CY2014Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3464000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1621000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9026000	USD
CY2014Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3382000	USD
CY2014Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	402481000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	414348000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	202869000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	287115000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	260908000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	122494000	USD
CY2014Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	80375000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	26207000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	16953000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	16854000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	59541000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	58955000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	365000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	366000	USD
CY2014Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	402500000	USD
CY2014Q3	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	63000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2034000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	419000	USD
CY2013Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	160000	USD
CY2014Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	515000	USD
CY2014Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	46000	USD
CY2013Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	3000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	366000	USD
CY2013Q4	us-gaap	Available For Sale Securities Pledged As Collateral AvailableForSaleSecuritiesPledgedAsCollateral	241911000	USD
CY2014Q3	us-gaap	Available For Sale Securities Pledged As Collateral AvailableForSaleSecuritiesPledgedAsCollateral	252630000	USD
CY2014Q3	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	47	Security
CY2013Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	77	Security
CY2014Q3	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	26432000	USD
CY2013Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	25850000	USD
CY2014Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	238000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	710000	USD
CY2013Q3	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	241000	USD
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	721000	USD
	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	1592000	USD
CY2013Q3	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	426000	USD
	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	1502000	USD
CY2014Q3	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	575000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1823000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-80312000	USD
CY2014Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	15524000	USD
CY2013Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	12995000	USD
CY2014Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	35737000	USD
CY2013Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	37560000	USD
CY2013Q3	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	70376000	USD
CY2012Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	150688000	USD
CY2011Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	381920	shares
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2013Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2014Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2014Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2013Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05205
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05205
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8107274	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8264548	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8106463	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8263737	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	422000	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	430000	USD
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	660000	USD
	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	811000	USD
CY2014Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	254000	USD
CY2013Q3	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	282000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1567000	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3947000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14896000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1560000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk</font><font style="font-family:inherit;font-size:10pt;"> – The Company grants commercial, residential and consumer loans to customers in its market area. Although the Company maintains a diversified loan portfolio, a significant portion of its customers’ ability to honor their contracts is dependent upon economic sectors for construction contractors, residential and non-residential building operators, sales finance, sub-dividers, developers, and various commercial and industrial businesses. Management evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if collateral is deemed necessary by the Company upon the extension of credit, is based on management’s credit evaluation of the customer. Collateral held varies, but generally includes real estate and equipment.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The types of securities the Company invests in are included in Note 2, “Securities Available for Sale” and the types of lending the Company engages in are included in Note 3, “Loans Receivable and Allowance for Loan Losses.”</font></div></div>
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	60000	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2013Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2014Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-281000	USD
CY2014Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24000	USD
CY2013Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-281000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2372000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1320000	USD
CY2014Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1534000	USD
CY2013Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	532000	USD
CY2014Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2163000	USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2193000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	333000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	320000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	161000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	184000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	23749000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18728000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-27000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2592000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4785000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2136000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8169000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6850000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	178000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	232000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	664000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	706000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	517000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	510000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	214000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	191000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	6358000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	7776000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	2592000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	18964000	USD
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16592000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	711000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	582000	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	986000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1116000	USD
CY2013Q4	us-gaap	Deposits Deposits	1000390000	USD
CY2014Q3	us-gaap	Deposits Deposits	989234000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2076000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2069000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.87
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.64
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.87
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.24
CY2014Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	2093779	USD
CY2014Q3	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	15.56
	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	11.52
	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	14.88
CY2013Q3	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	12.47
CY2014Q3	us-gaap	Equipment Expense EquipmentExpense	865000	USD
CY2013Q3	us-gaap	Equipment Expense EquipmentExpense	900000	USD
	us-gaap	Equipment Expense EquipmentExpense	2528000	USD
	us-gaap	Equipment Expense EquipmentExpense	2537000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1226000	USD
CY2014Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	403000	USD
CY2013Q3	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	647000	USD
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1938000	USD
	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	4056000	USD
CY2013Q3	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	1448000	USD
CY2014Q3	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	1375000	USD
	us-gaap	Fees And Commissions Depositor Accounts FeesAndCommissionsDepositorAccounts	4307000	USD
	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	3599000	USD
	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	3551000	USD
CY2013Q3	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	1273000	USD
CY2014Q3	us-gaap	Fees And Commissions Fiduciary And Trust Activities FeesAndCommissionsFiduciaryAndTrustActivities	1172000	USD
	us-gaap	Fees And Commissions Mortgage Banking FeesAndCommissionsMortgageBanking	1634000	USD
CY2014Q3	us-gaap	Fees And Commissions Mortgage Banking FeesAndCommissionsMortgageBanking	613000	USD
CY2013Q3	us-gaap	Fees And Commissions Mortgage Banking FeesAndCommissionsMortgageBanking	727000	USD
	us-gaap	Fees And Commissions Mortgage Banking FeesAndCommissionsMortgageBanking	2584000	USD
	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	705000	USD
CY2013Q3	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	283000	USD
CY2014Q3	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	270000	USD
	us-gaap	Fees And Commissions Other FeesAndCommissionsOther	789000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	784000	USD
CY2013Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	20352000	USD
CY2014Q3	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	15816000	USD
CY2014Q3	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	203000	USD
CY2013Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	613000	USD
CY2013Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	645702000	USD
CY2014Q3	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	666016000	USD
CY2013Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	25335000	USD
CY2014Q3	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	14358000	USD
CY2013Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	4	Contract
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	19	Contract
CY2014Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	5	Contract
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	5	Contract
CY2014Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	299000	USD
CY2013Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	3607000	USD
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	1755000	USD
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	4131000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	4131000	USD
CY2013Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	3607000	USD
CY2014Q3	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	321000	USD
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	1844000	USD
	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	4	Contract
	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	Contract
CY2014Q3	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	3	Contract
CY2013Q3	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0	Contract
CY2013Q3	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	0	USD
	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	4219000	USD
CY2014Q3	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	724000	USD
	us-gaap	Financing Receivable Modifications Subsequent Default Recorded Investment1 FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1	0	USD
CY2013Q4	us-gaap	Financing Receivable Recorded Investment30 To59 Days Past Due FinancingReceivableRecordedInvestment30To59DaysPastDue	3264000	USD
CY2014Q3	us-gaap	Financing Receivable Recorded Investment30 To59 Days Past Due FinancingReceivableRecordedInvestment30To59DaysPastDue	1857000	USD
CY2013Q4	us-gaap	Financing Receivable Recorded Investment60 To89 Days Past Due FinancingReceivableRecordedInvestment60To89DaysPastDue	699000	USD
CY2014Q3	us-gaap	Financing Receivable Recorded Investment60 To89 Days Past Due FinancingReceivableRecordedInvestment60To89DaysPastDue	32000	USD
CY2013Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2014Q3	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2013Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	647727000	USD
	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	490000	USD
CY2014Q3	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	665862000	USD
CY2013Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	19347000	USD
CY2014Q3	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	12623000	USD
CY2013Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	3963000	USD
CY2014Q3	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	1889000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41000	USD
CY2014Q3	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	469000	USD
CY2013Q3	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	157000	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	1668000	USD
	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	279000	USD
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	269000	USD
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-144000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	21718000	USD
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20044000	USD
CY2014Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20497000	USD
CY2013Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20923000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	216000	USD
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	365000	USD
CY2013Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	187000	USD
CY2014Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	72000	USD
CY2013Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	24659000	USD
CY2014Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	12599000	USD
CY2014Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	17375000	USD
CY2013Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	27349000	USD
CY2014Q3	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	1759000	USD
CY2013Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	676000	USD
CY2013Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	1160000	USD
CY2014Q3	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	1822000	USD
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6856000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1828000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5201000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	10052000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-221000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-281000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2372000	USD
CY2014Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1534000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1320000	USD
CY2013Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-532000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-249000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-11156000	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-50106000	USD
	us-gaap	Increase Decrease In Loans Held For Sale IncreaseDecreaseInLoansHeldForSale	-6214000	USD
	us-gaap	Increase Decrease In Loans Held For Sale IncreaseDecreaseInLoansHeldForSale	2228000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	2579000	USD
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-801000	USD
CY2014Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	460000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1209000	USD
CY2013Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	106000	USD
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	369000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	622000	USD
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	465000	USD
CY2013Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	8982000	USD
CY2014Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9477000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	27455000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	28663000	USD
CY2013Q3	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	41000	USD
CY2014Q3	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	9000	USD
	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	152000	USD
	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	24000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	22084000	USD
CY2013Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7739000	USD
CY2014Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	7351000	USD
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	23803000	USD
CY2013Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	884019000	USD
CY2014Q3	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	863401000	USD
CY2014Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	20213000	USD
CY2013Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	24565000	USD
	us-gaap	Interest Expense InterestExpense	3200000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	252000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	1216000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	1030000	USD
	us-gaap	Interest Expense InterestExpense	3881000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2840000	USD
CY2013Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1073000	USD
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3436000	USD
CY2014Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	924000	USD
CY2014Q3	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	73000	USD
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	412000	USD
CY2013Q3	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	124000	USD
	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	264000	USD
	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	33000	USD
	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	96000	USD
CY2014Q3	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	33000	USD
CY2013Q3	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	19000	USD
CY2014Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	11347000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	24974000	USD
CY2013Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	7766000	USD
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	28363000	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8447000	USD
CY2013Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7766000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	23574000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	25463000	USD
CY2014Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	63000	USD
CY2013Q3	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	298000	USD
CY2014Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2054000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	6065000	USD
	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2716000	USD
CY2013Q3	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	904000	USD
	us-gaap	Interest Paid InterestPaid	3974000	USD
	us-gaap	Interest Paid InterestPaid	3262000	USD
CY2013Q4	us-gaap	Interest Receivable InterestReceivable	3400000	USD
CY2014Q3	us-gaap	Interest Receivable InterestReceivable	3151000	USD
CY2013Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5584000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	104000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	16717000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	17593000	USD
CY2014Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5902000	USD
CY2014Q3	us-gaap	Liabilities Liabilities	1076874000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1086373000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1177812000	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1183392000	USD
CY2013Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	20965000	USD
CY2014Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	16019000	USD
CY2012Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	23166000	USD
CY2013Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	21252000	USD
CY2014Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	20425000	USD
CY2013Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	20098000	USD
CY2014Q3	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	680374000	USD
CY2013Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	671037000	USD
CY2013Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	650072000	USD
CY2014Q3	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	664355000	USD
CY2013Q4	us-gaap	Loans Receivable Held For Sale Net LoansReceivableHeldForSaleNet	1936000	USD
CY2014Q3	us-gaap	Loans Receivable Held For Sale Net LoansReceivableHeldForSaleNet	4164000	USD
CY2014Q3	us-gaap	Long Term Debt LongTermDebt	14986000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	16077000	USD
	us-gaap	Loss Contingency Date Of Dismissal LossContingencyDateOfDismissal	2013-08-23
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The nature of the Company’s business generates a certain amount of litigation involving matters arising out of the ordinary course of business. Except as described below, in the opinion of management, there are </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> legal proceedings that might have a material effect on the results of operations, liquidity, or the financial position of the Company at this time.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 25, 2012, Southeastern Pennsylvania Transportation Authority (“SEPTA”) filed a putative class action complaint in the United States District Court for the Middle District of Pennsylvania against the Company, the Bank and certain current and former directors and executive officers (collectively, the “Defendants”). The complaint alleges, among other things, that (i) in connection with the Company’s Registration Statement on Form S-3 dated February 23, 2010 and its Prospectus Supplement dated March 23, 2010, and (ii) during the purported class period of March 24, 2010 through October 27, 2011, the Company issued materially false and misleading statements regarding the Company’s lending practices and financial results, including misleading statements concerning the stringent nature of the Bank’s credit practices and underwriting standards, the quality of its loan portfolio, and the intended use of the proceeds from the Company’s March 2010 public offering of common stock. The complaint asserts claims under Sections 11, 12(a) and 15 of the Securities Act of 1933, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and seeks class certification, unspecified money damages, interest, costs, fees and equitable or injunctive relief. Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”), motions for appointment of Lead Plaintiff in this case were due by July 24, 2012. SEPTA was the sole movant and the Court appointed SEPTA Lead Plaintiff on August 20, 2012. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the PSLRA and the Court’s September 27, 2012 Order, SEPTA was given until October 26, 2012 to file an amended complaint and the Defendants until December 7, 2012 to file a motion to dismiss the amended complaint. SEPTA’s opposition to the Defendant’s motion to dismiss was originally due January 11, 2013. Under the PSLRA, discovery and all other proceedings in the case are stayed pending the Court’s ruling on the motion to dismiss. The September 27, 2012 Order specified that if the motion to dismiss were denied, the Court would schedule a conference to address discovery and the filing of a motion for class certification. On October 26, 2012, SEPTA filed an unopposed motion for enlargement of time to file its amended complaint in order to permit the parties and new defendants to be named in the amended complaint time to discuss plaintiff’s claims and defendants’ defenses. On October 26, 2012, the Court granted SEPTA’s motion, mooting its September 27, 2012 scheduling Order, and requiring SEPTA to file its amended complaint on or before January 16, 2013 or otherwise advise the Court of circumstances that require a further enlargement of time. On January 14, 2013, the Court granted SEPTA’s second unopposed motion for enlargement of time to file an amended complaint on or before March 22, 2013. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 4, 2013, SEPTA filed an amended complaint. The amended complaint expands the list of defendants in the action to include the Company’s former independent registered public accounting firm and the underwriters of the Company’s March 2010 public offering of common stock. In addition, among other things, the amended complaint extends the purported 1934 Exchange Act class period from March 15, 2010 through April 5, 2012. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the Court’s March 28, 2013 Second Scheduling Order, on May 28, 2013 all defendants filed their motions to dismiss the amended complaint, and on July 22, 2013 SEPTA filed its “omnibus” opposition to all of the defendants’ motions to dismiss. On </font><font style="font-family:inherit;font-size:10pt;">August 23, 2013</font><font style="font-family:inherit;font-size:10pt;">, all defendants filed reply briefs in further support of their motions to dismiss. On December 5, 2013, the Court ordered oral argument on the Orrstown Defendants’ motion to dismiss the amended complaint to be heard on February 7, 2014. Oral argument on the pending motions to dismiss SEPTA’s amended complaint was held on April 29, 2014. A decision from the court on the motions to dismiss is pending. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Second Scheduling Order stays all discovery in the case pending the outcome of the motions to dismiss, and informs the parties that, if required, a telephonic conference to address discovery and the filing of SEPTA’s motion for class certification will be scheduled after the Court’s ruling on the motions to dismiss. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The matter is currently progressing through the legal process. The Orrstown Defendants believe that the allegations in the amended complaint are without merit and intend to defend themselves vigorously against those claims, and as a result, no accrual for losses have been established for this matter.</font></div></div>
	us-gaap	Professional Fees ProfessionalFees	1829000	USD
	us-gaap	Professional Fees ProfessionalFees	1801000	USD
CY2014Q3	us-gaap	Occupancy Costs OccupancyCosts	535000	USD
	us-gaap	Occupancy Costs OccupancyCosts	1521000	USD
CY2013Q4	us-gaap	Other Assets OtherAssets	15067000	USD
CY2014Q3	us-gaap	Other Assets OtherAssets	11898000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-8477000	USD
CY2013Q3	us-gaap	Noninterest Expense NoninterestExpense	10537000	USD
CY2014Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	204000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	716000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	847000	USD
CY2013Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	231000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-55223000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-14896000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-41400000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2941000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16014000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	16311000	USD
	us-gaap	Net Income Loss NetIncomeLoss	7077000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	5177000	USD
	us-gaap	Net Income Loss NetIncomeLoss	10028000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	2109000	USD
CY2013Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	116371000	USD
CY2014Q3	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	125833000	USD
CY2014Q3	us-gaap	Noninterest Expense NoninterestExpense	10898000	USD
	us-gaap	Noninterest Expense NoninterestExpense	31813000	USD
	us-gaap	Noninterest Expense NoninterestExpense	32639000	USD
CY2014Q3	us-gaap	Noninterest Income NoninterestIncome	4752000	USD
CY2013Q3	us-gaap	Noninterest Income NoninterestIncome	4599000	USD
	us-gaap	Noninterest Income NoninterestIncome	14328000	USD
	us-gaap	Noninterest Income NoninterestIncome	13695000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2013Q3	us-gaap	Occupancy Costs OccupancyCosts	486000	USD
	us-gaap	Occupancy Costs OccupancyCosts	1696000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	151454000	USD
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	0	USD
	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	5743000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	7487000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-1895000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10000000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	68080000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	175014000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	155841000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1218000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	743000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-845000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-2967000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-296000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-665000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	2619000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5510000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1230000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4868000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-549000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	469000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	157000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	279000	USD
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	1668000	USD
CY2014Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1426000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	9155000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-688000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-8198000	USD
CY2013Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1325000	USD
CY2014Q3	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1025000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3865000	USD
	us-gaap	Other Noninterest Expense OtherNoninterestExpense	3648000	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-1767000	USD
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-587000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	19344000	USD
	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-19214000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.25
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.25
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassification</font><font style="font-family:inherit;font-size:10pt;"> – Certain amounts in the </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;"> consolidated financial statements have been reclassified to conform to the 2014 presentation.</font></div></div>
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	2175000	USD
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	1079000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-2753000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	25519000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	32201000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	15670000	USD
CY2014Q3	us-gaap	Professional Fees ProfessionalFees	653000	USD
CY2013Q3	us-gaap	Professional Fees ProfessionalFees	463000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	26441000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	25293000	USD
CY2014Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-2900000	USD
CY2013Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	0	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-2900000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1400000	USD
CY2014Q3	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	1128000	USD
CY2013Q4	us-gaap	Real Estate Acquired Through Foreclosure RealEstateAcquiredThroughForeclosure	987000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	21039000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	11091000	USD
CY2014Q3	us-gaap	Restricted Investments RestrictedInvestments	9334000	USD
CY2013Q4	us-gaap	Restricted Investments RestrictedInvestments	9921000	USD
CY2014Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	57933	USD
CY2013Q3	us-gaap	Restricted Stock Expense RestrictedStockExpense	4346	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	13037	USD
	us-gaap	Restricted Stock Expense RestrictedStockExpense	66625	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17227000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27255000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	20319	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	150580	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	206063	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.20
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.14
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	31.81
	us-gaap	Share Based Compensation ShareBasedCompensation	79000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	125000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	223788	shares
CY2014Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	164306	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	35164	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	37.00
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	21.14
CY2014Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	150580	shares
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	40.14
CY2014Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	31.14
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y2M27D
CY2014Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	56279000	USD
CY2014Q3	us-gaap	Taxes Other TaxesOther	129000	USD
	us-gaap	Taxes Other TaxesOther	443000	USD
	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	2201000	USD
	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	341000	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	59032000	USD
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	235	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	67	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	21609	shares
CY2014Q3	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	3668	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	15434	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	6707	shares
	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	157207	shares
	us-gaap	Stock Issued During Period Shares Share Based Compensation Gross StockIssuedDuringPeriodSharesShareBasedCompensationGross	26610	shares
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	3000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	182000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	374000	USD
CY2014Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	4000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	112000	USD
CY2013Q3	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	77000	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	12000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	91439000	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	106518000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	87694000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	89638000	USD
	us-gaap	Taxes Other TaxesOther	710000	USD
CY2013Q3	us-gaap	Taxes Other TaxesOther	222000	USD
CY2014Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11000	shares
CY2013Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8089000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8091000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8113000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8122000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8111000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8089000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8091000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8109000	shares
CY2013Q4	orrf	Accumulated Specific Charges To Value Real Estate Owned AccumulatedSpecificChargesToValueRealEstateOwned	411000	USD
CY2014Q3	orrf	Accumulated Specific Charges To Value Real Estate Owned AccumulatedSpecificChargesToValueRealEstateOwned	565000	USD
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	811	shares
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	811	shares
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	20000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	20000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates –</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Material estimates that are particularly susceptible to significant change relate to the determination of the allowance for losses on loans and the valuation of real estate acquired in connection with foreclosures or in satisfaction of loans, and the valuation allowance required on its deferred tax assets. In connection with the determination of the allowance for losses on loans and foreclosed real estate, management obtains independent appraisals for significant properties.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">While management uses available information to recognize losses on loans and foreclosed real estate, future additions to the allowances may be necessary based on changes in local economic conditions, and our borrowers' ability to manage their debt through different business cycles. In addition, regulatory agencies, as an integral part of their examination process, periodically review the Company’s allowance for losses on loans and foreclosed real estate. Such agencies may require the Company to recognize additions to the allowance based on their judgments concerning information available to them at the time of their examination. Because of these factors, management’s estimate of credit losses inherent in the loan portfolio and the related allowance may change in the near term.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has established a full valuation allowance on its net deferred tax assets, based on the Company’s previous taxable losses, projections for future taxable income, and other available evidence, in which management determined it was “more likely than not” that some portion of the asset may not be realized. Management may need to modify its judgment in this regard from one quarter to the next, and should continued improvement occur in operating performance, the need for a full valuation allowance may be reduced or eliminated.</font></div></div>
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q3	orrf	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInAOCI	2420000	USD
CY2013Q4	orrf	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInAOCI	1560000	USD
CY2013Q4	orrf	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLossesAccumulatedInAOCI	9026000	USD
CY2014Q3	orrf	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLossesAccumulatedInAOCI	3382000	USD
CY2013Q4	orrf	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInAOCI	7466000	USD
CY2014Q3	orrf	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Aoci AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInAOCI	962000	USD
CY2014Q3	orrf	Available For Sale Securities Mortgage Backed Securities And Collateralized Mortgage Obligations Amortized Cost AvailableForSaleSecuritiesMortgageBackedSecuritiesAndCollateralizedMortgageObligationsAmortizedCost	325557000	USD
CY2014Q3	orrf	Available For Sale Securities Mortgage Backed Securities And Collateralized Mortgage Obligations Fair Value AvailableForSaleSecuritiesMortgageBackedSecuritiesAndCollateralizedMortgageObligationsFairValue	326310000	USD
CY2014Q3	orrf	Balance Of Loans Serviced For Others BalanceOfLoansServicedForOthers	316365000	USD
CY2014Q3	orrf	Minimum Amount Of Loan On Which Review Have Been Made Annually MinimumAmountOfLoanOnWhichReviewHaveBeenMadeAnnually	1000000	USD
CY2013Q4	orrf	Financing Receivable Modified Balance End Of Period Number Of Contract FinancingReceivableModifiedBalanceEndOfPeriodNumberOfContract	12	Contract
CY2014Q3	orrf	Impaired Financing Receivables Allocated Allowance ImpairedFinancingReceivablesAllocatedAllowance	4393000	USD
CY2014Q3	orrf	Financing Receivable Modified Balance End Of Period Number Of Contract FinancingReceivableModifiedBalanceEndOfPeriodNumberOfContract	25	Contract
CY2013Q4	orrf	Balance Of Loans Serviced For Others BalanceOfLoansServicedForOthers	322653000	USD
CY2013Q3	orrf	Collection And Problem Loan CollectionAndProblemLoan	184000	USD
CY2014Q3	orrf	Collection And Problem Loan CollectionAndProblemLoan	215000	USD
	orrf	Collection And Problem Loan CollectionAndProblemLoan	533000	USD
	orrf	Collection And Problem Loan CollectionAndProblemLoan	565000	USD
CY2014Q3	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Charged Recovery To Noninterest Expense ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureChargedRecoveryToNoninterestExpense	-245000	USD
	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Charged Recovery To Noninterest Expense ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureChargedRecoveryToNoninterestExpense	-70000	USD
CY2013Q3	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Charged Recovery To Noninterest Expense ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureChargedRecoveryToNoninterestExpense	76000	USD
	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Charged Recovery To Noninterest Expense ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureChargedRecoveryToNoninterestExpense	-184000	USD
CY2013Q4	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Liability ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureLiability	529000	USD
CY2014Q3	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Liability ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureLiability	345000	USD
	orrf	Contractual Term To Restore To Accrual Status ContractualTermToRestoreToAccrualStatus	P9M
	orrf	Cumulative Loss Position Significant Negative Evidence Against Realizability Of Deferred Tax Asset Period CumulativeLossPositionSignificantNegativeEvidenceAgainstRealizabilityOfDeferredTaxAssetPeriod	P3Y
CY2013Q4	orrf	Cumulative Loss Position Significant Negative Evidence Against Realizability Of Deferred Tax Asset Period CumulativeLossPositionSignificantNegativeEvidenceAgainstRealizabilityOfDeferredTaxAssetPeriod	P3Y
CY2014Q3	orrf	Debt Securities Other Than Temporarily Impaired DebtSecuritiesOtherThanTemporarilyImpaired	0	USD
CY2013Q4	orrf	Debt Securities Other Than Temporarily Impaired DebtSecuritiesOtherThanTemporarilyImpaired	0	USD
	orrf	Deferred Tax Assets Charitable Contribution Carryforwards Expiration Period DeferredTaxAssetsCharitableContributionCarryforwardsExpirationPeriod	2019
CY2014Q3	orrf	Deferred Tax Assets Low Income Housing Credit Carry Forward DeferredTaxAssetsLowIncomeHousingCreditCarryForward	1348000	USD
CY2013Q4	orrf	Deferred Tax Assets Low Income Housing Credit Carry Forward DeferredTaxAssetsLowIncomeHousingCreditCarryForward	1022000	USD
	orrf	Deferred Tax Assets Low Income Housing Credit Carryforward Expiration Period DeferredTaxAssetsLowIncomeHousingCreditCarryforwardExpirationPeriod	2034
CY2013Q4	orrf	Deferred Tax Assets Nonaccrual Loan Interest DeferredTaxAssetsNonaccrualLoanInterest	341000	USD
CY2014Q3	orrf	Deferred Tax Assets Nonaccrual Loan Interest DeferredTaxAssetsNonaccrualLoanInterest	178000	USD
CY2013Q4	orrf	Deferred Tax Assets Off Balance Sheet Reserves DeferredTaxAssetsOffBalanceSheetReserves	204000	USD
CY2014Q3	orrf	Deferred Tax Assets Off Balance Sheet Reserves DeferredTaxAssetsOffBalanceSheetReserves	177000	USD
	orrf	Deferred Tax Assets Operating Loss Carryforwards Expiration Period DeferredTaxAssetsOperatingLossCarryforwardsExpirationPeriod	2032
CY2013Q4	orrf	Deferred Tax Assets Retirement Plans And Salary Continuation DeferredTaxAssetsRetirementPlansAndSalaryContinuation	1585000	USD
CY2014Q3	orrf	Deferred Tax Assets Retirement Plans And Salary Continuation DeferredTaxAssetsRetirementPlansAndSalaryContinuation	1667000	USD
CY2013Q4	orrf	Deferred Tax Liabilities Purchase Accounting Adjustments DeferredTaxLiabilitiesPurchaseAccountingAdjustments	495000	USD
CY2014Q3	orrf	Deferred Tax Liabilities Purchase Accounting Adjustments DeferredTaxLiabilitiesPurchaseAccountingAdjustments	439000	USD
CY2014Q3	orrf	Deferred Tax Liabilities Unrealized Gains On Available For Sale Securities Gross DeferredTaxLiabilitiesUnrealizedGainsOnAvailableForSaleSecuritiesGross	27000	USD
CY2013Q4	orrf	Deferred Tax Liabilities Unrealized Gains On Available For Sale Securities Gross DeferredTaxLiabilitiesUnrealizedGainsOnAvailableForSaleSecuritiesGross	0	USD
CY2014Q3	orrf	Financing Receivable Modified Balance End Of Period FinancingReceivableModifiedBalanceEndOfPeriod	4153000	USD
CY2013Q4	orrf	Financing Receivable Modified Balance End Of Period FinancingReceivableModifiedBalanceEndOfPeriod	7535000	USD
CY2014Q3	orrf	Held To Maturity Or Trading Securities HeldToMaturityOrTradingSecurities	0	USD
CY2013Q4	orrf	Held To Maturity Or Trading Securities HeldToMaturityOrTradingSecurities	0	USD
CY2013Q4	orrf	Impaired Financing Receivables Allocated Allowance ImpairedFinancingReceivablesAllocatedAllowance	3238000	USD
	orrf	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	-253000	USD
	orrf	Increase Decrease In Interest Payable And Other Liabilities IncreaseDecreaseInInterestPayableAndOtherLiabilities	5474000	USD
	orrf	Maturity Of Interest Bearing Deposits MaturityOfInterestBearingDeposits	P90D
	orrf	Maximum Percentage Of Credit Worthiness Of Borrower MaximumPercentageOfCreditWorthinessOfBorrower	0.43
	orrf	Maximum Percentage Of Loan To Value Ratio Of Value Of Real Estate Taken As Collateral MaximumPercentageOfLoanToValueRatioOfValueOfRealEstateTakenAsCollateral	0.90
	orrf	Maximum Percentage Of Loan To Value Ratio Upon Loan Origination MaximumPercentageOfLoanToValueRatioUponLoanOrigination	0.80
CY2014Q3	orrf	Minimum Amount Of Loan Rated As Substandard MinimumAmountOfLoanRatedAsSubstandard	250000	USD
	orrf	Write Down Of Other Real Estate Owned WriteDownOfOtherRealEstateOwned	154000	USD
	orrf	Write Down Of Other Real Estate Owned WriteDownOfOtherRealEstateOwned	29000	USD
	orrf	Securities Purchased Not Yet Settled SecuritiesPurchasedNotYetSettled	34578000	USD
CY2014Q3	orrf	Minimum Amount On Which Annual Updated Appraisals For Criticized Loans Is Required MinimumAmountOnWhichAnnualUpdatedAppraisalsForCriticizedLoansIsRequired	250000	USD
	orrf	Non Interest Income Expense Net NonInterestIncomeExpenseNet	-38000	USD
	orrf	Non Interest Income Expense Net NonInterestIncomeExpenseNet	364000	USD
CY2014Q3	orrf	Non Interest Income Expense Net NonInterestIncomeExpenseNet	40000	USD
CY2013Q3	orrf	Non Interest Income Expense Net NonInterestIncomeExpenseNet	44000	USD
CY2014Q3	orrf	Number Of Legal Proceedings That Have Material Effect NumberOfLegalProceedingsThatHaveMaterialEffect	0	Claim
	orrf	Number Of Notes Split NumberOfNotesSplit	2	Note
	orrf	Number Of Offices NumberOfOffices	22	Office
	orrf	Other Real Estate Foreclosed Assets Valuation Adjustment OtherRealEstateForeclosedAssetsValuationAdjustment	29000	USD
CY2014Q3	orrf	Other Real Estate Foreclosed Assets Valuation Adjustment OtherRealEstateForeclosedAssetsValuationAdjustment	145000	USD
	orrf	Other Real Estate Foreclosed Assets Valuation Adjustment OtherRealEstateForeclosedAssetsValuationAdjustment	154000	USD
CY2013Q3	orrf	Other Real Estate Foreclosed Assets Valuation Adjustment OtherRealEstateForeclosedAssetsValuationAdjustment	29000	USD
	orrf	Percentage Of Deferred Tax Assets PercentageOfDeferredTaxAssets	0.50
	orrf	Percentage Of Strong Loan To Value PercentageOfStrongLoanToValue	0.70
	orrf	Provision For Income Taxes Related To Net Security Gains ProvisionForIncomeTaxesRelatedToNetSecurityGains	584000	USD
CY2013Q3	orrf	Provision For Income Taxes Related To Net Security Gains ProvisionForIncomeTaxesRelatedToNetSecurityGains	55000	USD
	orrf	Provision For Income Taxes Related To Net Security Gains ProvisionForIncomeTaxesRelatedToNetSecurityGains	98000	USD
CY2014Q3	orrf	Provision For Income Taxes Related To Net Security Gains ProvisionForIncomeTaxesRelatedToNetSecurityGains	164000	USD
CY2013Q3	orrf	Real Estate Owned Expenses RealEstateOwnedExpenses	55000	USD
	orrf	Real Estate Owned Expenses RealEstateOwnedExpenses	261000	USD
	orrf	Real Estate Owned Expenses RealEstateOwnedExpenses	115000	USD
CY2014Q3	orrf	Real Estate Owned Expenses RealEstateOwnedExpenses	201000	USD
	orrf	Securities Purchased Not Yet Settled SecuritiesPurchasedNotYetSettled	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000826154
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8263737	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ORRSTOWN FINANCIAL SERVICES INC
	dei	Trading Symbol TradingSymbol	ORRF

Files In Submission

Name	View Source	Status
0000826154-14-000030-index-headers.html	Edgar Link	pending
0000826154-14-000030-index.html	Edgar Link	pending
0000826154-14-000030.txt	Edgar Link	pending
0000826154-14-000030-xbrl.zip	Edgar Link	pending
ex101q32014.htm	Edgar Link	pending
ex311q32014.htm	Edgar Link	pending
ex312q32014.htm	Edgar Link	pending
ex321q32014.htm	Edgar Link	pending
ex322q32014.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
orrf-20140930.xml	Edgar Link	completed
orrf-20140930.xsd	Edgar Link	pending
orrf-20140930_cal.xml	Edgar Link	unprocessable
orrf-20140930_def.xml	Edgar Link	unprocessable
orrf-20140930_lab.xml	Edgar Link	unprocessable
orrf-20140930_pre.xml	Edgar Link	unprocessable
orrf-2014930x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORRF
ORRSTOWN FINANCIAL SERVICES INC Stock $orrf

2014 Q4 Form 10-Q Financial Statement

#000082615414000030 Filed on November 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORRF ORRSTOWN FINANCIAL SERVICES INC Stock $orrf

2014 Q4 Form 10-Q Financial Statement

#000082615414000030 Filed on November 07, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORRF
ORRSTOWN FINANCIAL SERVICES INC Stock $orrf